1 penny stock mistake to avoid in 2025

Ben McPoland explores a rookie error common to penny stock investing, and also highlights a 19p small-cap that looks like a buy for his portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Stacks of coins

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The allure of a penny stock can be intoxicating for some novice investors. Often, the low price per share gives the illusion of affordability, making it easier for individuals with limited capital to invest.

In other words, an investor with £200 might prefer to buy 1,000 shares of a 20p stock rather than 2 shares of a FTSE 100 stock that’s trading for £100. They might equate a low share price (20p) with being ‘cheap’, and a high price (£100) with being ‘expensive’.

However, judging a stock based on price alone is a common pitfall that investors should avoid.

Should you invest £1,000 in Abrdn right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Abrdn made the list?

See the 6 stocks

Focus on fundamentals

A company’s market cap is calculated by multiplying its share price by its shares outstanding.

For example, Lloyds‘ share price is 54p. Yet it’s certainly no penny stock. In fact, with a hefty £33bn market cap, it’s the 20th-largest firm listed in London. All this tells us is that the bank has a huge number of shares knocking about (around 60bn in fact).

In contrast, Judges Scientific is a small AIM-listed company specialising in scientific instruments. Despite having just a £577m market cap, making Lloyds roughly 57 times larger, Judges Scientific’s share price is 8,700p (£87). There are far fewer shares.

In this case, an investor with £200 can either buy 370 shares of Lloyds or 2 shares of Judges Scientific (costing £174). However, what truly matters is the underlying business, its growth potential, and prospects for future profits — not whether the share price appears high or low.

Valuation

Next, valuation is crucial to consider. As Warren Buffett says: “Price is what you pay, value is what you get.”

A 20p stock might end up eye-wateringly expensive (a terrible investment), while the £100 stock could prove to be an absolute steal. And vice versa.

A cheap UK small-cap

I have a 19p small-cap stock in my own portfolio. It’s called hVIVO (LSE: HVO). The £133m firm is a leader in the testing of infectious diseases using human challenge studies. This is where healthy volunteers are infected with a pathogen to study disease progression and the effectiveness of a potential treatment.

hVIVO has its own state-of-the-art quarantine facility and recruits volunteers through its FluCamp platform. It works with four of the top 10 global pharmaceutical companies and is growing nicely.

Unfortunately, the share price has slumped 34% since mid-November (although it’s still up 285% in five years). The main reason for this hammering appears to be Donald Trump’s nomination of vaccine-sceptic Robert Kennedy Jr to lead the Department of Health and Human Services.

The risk here is that his appointment could lead to less funding for vaccine research and development, potentially impacting hVIVO’s growth trajectory.

However, this is speculation and Kennedy might not even get the job. On 17 December, vaccine giant Pfizer said it doesn’t expect any major policy changes around vaccinations in 2025.

Meanwhile, hVIVO recently signed an £11.5m contract with a top-tier pharma client to test an antiviral for respiratory syncytial virus (RSV). It also reaffirmed full-year revenue guidance of £62m, and is targeting £100m by 2028.

After this slump, the stock is trading on a forward price-to-earnings (P/E) ratio of just 11.7. That looks very cheap to me, which is why I’ll be snapping up a few more shares in January.

Should you buy Abrdn now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in hVIVO Plc. The Motley Fool UK has recommended Judges Scientific Plc and Lloyds Banking Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

We think earning passive income has never been easier

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Investing Articles

At a 52-week low but forecast to rise 73%! Is this growth share the FTSE’s top recovery play? 

This FTSE 100 growth share has taken an absolute beating over the past two years but Harvey Jones says the…

Read more »

Investing Articles

This FTSE 250 share offers a juicy 9.8% yield. Will it last?

This well-known FTSE 250 share has a percentage dividend yield approaching double digits. Should Christopher Ruane add the income share…

Read more »

Investing Articles

Is a £333,000 portfolio enough to retire and live off passive income?

A third of a million pounds can generate a serious amount of passive income, but relying on this sum alone…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing For Beginners

Why FTSE 100 investors should pay attention to ‘Liberation Day’

Jon Smith explains why the upcoming tariff announcement from across the pond could have an impact on the FTSE 100,…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Here’s why Nvidia stock fell 13% in March

The Nvidia stock price rise was looking unstoppable. Should investors now be wondering if the same might be true of…

Read more »

US Stock

It’s ISA deadline week! Here’s my 3-step game plan

Jon Smith tries to calm the hype around the last minute ISA rush to buy stocks and explains why he's…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£10,000 invested in BAE Systems shares at Christmas is now worth…

BAE Systems shares have been surging in the FTSE 100 in 2025, driven higher by the wavering US commitment to…

Read more »

Investing Articles

Up 19% in 2 weeks, can the Tesla share price rebound further?

Tesla's first-quarter delivery numbers came out today. Will they help persuade our writer to invest his money at the current…

Read more »